Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) FCF Margin (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed FCF Margin for 9 consecutive years, with 15.54% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 156.0% to 15.54% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 8.61% through Dec 2025, down 275.0% year-over-year, with the annual reading at 8.61% for FY2025, 275.0% down from the prior year.
  • FCF Margin hit 15.54% in Q4 2025 for Inspire Medical Systems, down from 25.87% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 35.89% in Q3 2024 to a low of 28.77% in Q1 2021.
  • Historically, FCF Margin has averaged 1.13% across 5 years, with a median of 1.57% in 2021.
  • Biggest five-year swings in FCF Margin: skyrocketed 19543bps in 2021 and later tumbled -1732bps in 2023.
  • Year by year, FCF Margin stood at 1.42% in 2021, then soared by 843bps to 13.44% in 2022, then crashed by -64bps to 4.8% in 2023, then soared by 191bps to 13.98% in 2024, then grew by 11bps to 15.54% in 2025.
  • Business Quant data shows FCF Margin for INSP at 15.54% in Q4 2025, 25.87% in Q3 2025, and 2.91% in Q2 2025.